Advertisement
Persons > All
Europe
America
Asia
Africa, AUS & NZ
Academic/Research
Industry Business
Industry Technical
Government
Find below all kinds of persons.Total search results: 3394 | Ordered by Organisation (Group) (descending)
1 2 3 ... 11 12 13 ... 32 33 34
Person | Position | Organisation (Group) | Country |
---|---|---|---|
Watanabe, Yoshiaki (Rigaku 201906 Senior EVP) | President/Director/Head Business Group/Unit/Division | Rigaku (Group) | Japan |
Hughes, Chris (Revvity 202307 Managing Director North Europe) | Managing Director | Revvity (Group) | United States (USA) |
Willoe, Kevin (Revvity 202307 SVP + General Manager of Revvity Signals Software) | General Manager (management) | Revvity (Group) | |
Cutillas, Pedro (Activiomics 201004 scientific co-founder) | Company Founder | Retroscreen Virology (Group) | United Kingdom (GB) |
Denny, Kym (Retroscreen Virology 201307 CEO) | Chief Executive Officer (CEO) | Retroscreen Virology (Group) | United Kingdom (GB) |
Edelman, Jonathan (Restek 201808 Business Development Manager) | Business Development Manager / Strategy Manager | Restek (Group) | United States (USA) |
Harshbarger, Robert (Restek 201309– VP Sales + Marketing before GE Healthcare + Agilent + Promega) | Sales Manager / Marketing Manager | Restek (Group) | United States (USA) |
Kelley, Sean (Restek 201405 Marketing Communications Officer) | Public Relations Manager / Investor Relations Manager | Restek (Group) | United States (USA) |
Lake, Rick (Restek 201808 VP Marketing) | Sales Manager / Marketing Manager | Restek (Group) | United States (USA) |
Hirsch, Christian (Showa Denko 202004 General Manager Shodex Business EMEA at Showa Denko Europe GmbH) | General Manager (management) | Resonac (Group) | Germany |
Steinhauser, Lisa (Showa Denko 201306 Customer Support Manager Shodex Businees EMEA + Russia) | Regional manager | Resonac (Group) | Germany |
David, Frank (Research Institute of Chromatography 201407) | n. a. | Research Institute for Chromatography (R.I.C.) (Group) | Belgium |
Sandra, Koen (Research Institute for Chromatography) | Research & Development Manager | Research Institute for Chromatography (R.I.C.) (Group) | Belgium |
Gebski, Christine (Repligen 202308 SVP Filtration + Chromatography before Thermo Fisher) | President/Director/Head Business Group/Unit/Division | Repligen Corporation (Nasdaq: RGEN) | United States (USA) |
Hunt, Tony J. (Repligen 2015– CEO joined 2014 as COO before Life Technologies + Applied Biosystems) | Chief Executive Officer (CEO) | Repligen Corporation (Nasdaq: RGEN) | United States (USA) |
Roblin, David (Relation Therapeutics 202206– CEO before Crick Institute + Creabilis + Pfizer + Bayer) | Chief Operating Officer (COO) | Relation Therapeutics Ltd. | United Kingdom (GB) |
Davies, Paul (Refeyn 202305– VP Sales + Marketing) | Sales Manager / Marketing Manager | Refeyn (Group) | United Kingdom (GB) |
Fernandez, Anthony (Refeyn 202101–202301 CEO before Teledyne + Xennia Technology LEFT 1/23 for health reasons) | Chief Executive Officer (CEO) | Refeyn (Group) | United Kingdom (GB) |
Flint, Jonathan (Refeyn 202101 Board Chair) | Board member, non-executive | Refeyn (Group) | United Kingdom (GB) |
Langhorst, Matthias (Refeyn 202308 Chief Product Officer) | Product Manager (personnel) | Refeyn (Group) | United Kingdom (GB) |
MacKay, Gerry (Refeyn 202401– CEO before Sartorius + Millipore + BioOutsource) | Chief Executive Officer (CEO) | Refeyn (Group) | United Kingdom (GB) |
Sirec, Teja (Refeyn 202309 Marketing Director) | Sales Manager / Marketing Manager | Refeyn (Group) | United Kingdom (GB) |
Martin, Rachel (Elsevier 201008) | n. a. | Reed Elsevier (Group) | Netherlands |
van Mierle, Mark (Reed Elsevier 201301 Managing Director Elsevier Pharmaceutical + Biotech Group) | Managing Director | Reed Elsevier (Group) | Netherlands |
Cojocaru-Uleia, Anamaria (Redox (RO 201405 Sales Manager) | Sales Manager / Marketing Manager | Redox (RO) | Romania |
Sidler, Michael (Redalpine 201210) | n. a. | Redalpine Venture Partners AG | Switzerland |
Bamforth, Mark R. (Brammer Bio 201903 CEO + Co-Founder) | Chief Executive Officer (CEO) | Recipharm (Group) | United States (USA) |
Ridgway, Peter (Reach Separations 201403 Business Development Director) | Business Development Manager / Strategy Manager | Reach Separations Ltd. | United Kingdom (GB) |
Spoto, Mark (Razor’s Edge Ventures 201302 Managing Director) | Managing Director | Razor’s Edge Ventures LLC | United States (USA) |
Baldry, Lindsay (Ramarketing 201603– before Pharma Nord + Admiral PR + Scott Partnership) | Public Relations Manager / Investor Relations Manager | Ramarketing (Group) | United Kingdom (GB) |
Sehgal, Raman (Ramarketing & PR Ltd 2009– Managing Director + Founder) | Managing Director | Ramarketing (Group) | United Kingdom (GB) |
Chen, Robert (RAE Systems 201204 CEO) | Chief Executive Officer (CEO) | RAE Systems Inc. | United States (USA) |
Toney, Chris (RAE Systems 201204– COO before Agilent VP + General Manager GC/MS) | Chief Operating Officer (COO) | RAE Systems Inc. | United States (USA) |
Franklin, Nicole (Racepoint Global 201406) | Public Relations Manager / Investor Relations Manager | Racepoint Global (Group) | United States (USA) |
Cowan, Paul (Quotient Bioscience 200904 CEO) | Chief Executive Officer (CEO) | Quotient Bioscience (Group) | United Kingdom (GB) |
Burdett, Roger (Quotient Bioresearch 201201 CEO) | Chief Executive Officer (CEO) | Quotient Bioresearch (Group) | United Kingdom (GB) |
Cameron, Gordon (Quotient Bioresearch 2007– CFO before Acambis 2004–200706 CEO before CFO before NM Rothschild) | Chief Financial Officer (CFO) | Quotient Bioresearch (Group) | United Kingdom (GB) |
Egerton, Mark (Quotient Bioresearch 201010) | n. a. | Quotient Bioresearch (Group) | United Kingdom (GB) |
Morrissey, Ian (Quotient Bioscience 201109 Director of Microbiology at Quotient Bioresearch) | Laboratory Manager (industry) | Quotient Bioresearch (Group) | United Kingdom (GB) |
Pleasance, Steve (Quotient Bioresearch 201210 Managing Director of Bioanalytical Services) | Managing Director | Quotient Bioresearch (Group) | United Kingdom (GB) |
Webber, Guy (Quotient Bioresearch 201003 Head of In Vitro Sciences) | n. a. | Quotient Bioresearch (Group) | United Kingdom (GB) |
Stackawitz, Jeremy (Quotient Bioscience 200904– CEO of Quotient Biodiagnostics before Ortho Clinical Diagnostics) | Chief Executive Officer (CEO) | Quotient (Group) | United Kingdom (GB) |
Wagner, Charles F., Jr. (JnJ 201506– CFO at Ortho-Clinical Diagnostics before CFO at Bruker + Millipore + Bain & Co) | Chief Financial Officer (CFO) | Quidel (Group) | United States (USA) |
Besson, Charles (Questel 201609 CEO) | Chief Executive Officer (CEO) | Questel (FR) | France |
Rusckowski, Steve (Quest Diagnostics 201205– CEO before Philips CEO of Philips Healthcare sector since 2006) | Chief Executive Officer (CEO) | Quest Diagnostics (Group) | United States (USA) |
Etroy, Stephane (Québec (govt) 201606 Head of Europe Private Equity at CDPQ) | Investment Manager | Québec (govt region) | Canada |
Lescure, Roland (Québec (govt) 201606 EVP + Chief Investment Officer at CDPQ) | Investment Manager | Québec (govt region) | Canada |
Japczynski, Scott (Quantum Analytics 201810 EVP) | President/Director/Head Business Group/Unit/Division | Quantum Analytics (US) | United States (USA) |
Hrusovsky, Kevin (Quanterix 201507 CEO before PerkinElmer + Caliper) | Chief Executive Officer (CEO) | Quanterix (Group) | United States (USA) |
Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) | Managing Partner (investment firm) | Quadriga Capital Eigenkapitalberatung GmbH | |
Lam, Zamas (QPS 201606 SVP + Global Head of Pre-clinical Development) | President/Director/Head Business Group/Unit/Division | QPS (Group) | United States (USA) |
Sood, Nitin (Qiagen 202401 SVP Head Life Science Business Area formerly NuGen + PerkinElmer + Boreal Genomics + Agilent) | President/Director/Head Business Group/Unit/Division | Qiming (Group) | China |
Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Netherlands |
Crutchfield, Brad (Qiagen 201506–2016 SVP before Illumina + NanoString + Bio-Rad STEPPED DOWN 2016) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Netherlands |
Schweins, Thomas (Qiagen 200402– VP Corporate Strategy before Boston Consulting Dusseldorf before Hoechst) | Corporate Strategy Manager | Qiagen (Group) | Netherlands |
Crowley, Erin (Q Laboratories 201802 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Q Laboratories Inc. | United States (USA) |
Özbal, Can (PureHoney Technologies 2014– CEO + Co-Founder before BIOCIUS + BioTrove) | Chief Operating Officer (COO) | PureHoney Technologies (US) | United States (USA) |
Cooks, R. Graham (Purdue Univ Prof Dept of Chemistry, Aston Labs) | Professor | Purdue University | United States (USA) |
Regnier, Fred (Purdue Univ 201404 Prof Emeritus + Co-founder of Novilytic) | Professor | Purdue University | United States (USA) |
Wirth, Mary J. (Purdue Univ 201506 Professor at Dept of Chemistry) | Professor | Purdue University | United States (USA) |
Leitner, Michael (Public Health PR 201009 Managing Director) | Managing Director | Public Health PR-Projektgesellschaft mbH | Austria |
Hixson, Harry F., jr.(Sequenom 201008 CEO before PsychoGenics 200507) | Chief Executive Officer (CEO) | PsychoGenics Inc. | United States (USA) |
Schatz, Peer M. (Resolve BioSciences 202012 Chairman + Co-Founder before Qiagen 1993–201910 CEO RESIGNED 10/19) | Board member, non-executive | PS Capital Management GmbH (Peer Schatz) | Germany |
Hudalla, Christopher J. (908 Devices 201706 CSO + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ProVerde Laboratories (US) | United States (USA) |
D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America) | Chief Business Officer (CBO) | Proteros (Group) | United States (USA) |
Haigh, Brantley (Proteros 201008– Business Development US West Coast working for Proteros since 4 years) | Business Development Manager / Strategy Manager | Proteros (Group) | United States (USA) |
Neuefeind, Torsten (Proteros Biostructures 200610 Managing Director) | Managing Director | Proteros (Group) | Germany |
Parge, Hans (Proteros 201008– technical ambassador in US former Director Structural Biology Pfizer La Jolla) | Business Development Manager / Strategy Manager | Proteros (Group) | United States (USA) |
Reinemer, Peter (Proteros Biostructures 201405– COO before SVP BusDev + Operations before EVP Scientific Marketing) | Sales Manager / Marketing Manager | Proteros (Group) | Germany |
Schiewe, Hajo (Proteros 200708 EVP Business Development) | Business Development Manager / Strategy Manager | Proteros (Group) | Germany |
Woodrow, Gordon (Proteros Biostructures 201008 EVP Strategic Alliances) | Business Development Manager / Strategy Manager | Proteros (Group) | United Kingdom (GB) |
Epstein, Barry (Proteomics International 201201 VP Marketing) | Sales Manager / Marketing Manager | Proteomics International Pty Ltd. | Australia |
Lipscombe, Richard (Proteomics International 201201 Managing Director) | Managing Director | Proteomics International Pty Ltd. | Australia |
Ballerini, Maurizio (Proteomedix 202006– VP Market Development EMEA before MDxHealth + GenProbe + Stryker + Randox) | Sales Manager / Marketing Manager | Proteomedix AG | Switzerland |
Brühlmann, Christian (Proteomedix 202001 COO/CFO) | Chief Operating Officer (COO) | Proteomedix AG | Switzerland |
Lubenow, Helge (Proteomedix 202001– CEO before Consultant before 1997–2015 at Qiagen) | Chief Executive Officer (CEO) | Proteomedix AG | Switzerland |
Schiess, Ralph (Proteomedix 202001 CSO + Co-Founder before CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Proteomedix AG | Switzerland |
Gooley, Andrew (Proteome Systems 200205 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Proteome Systems (Group) | Australia |
Williams, Keith (Proteome Systems 200012 CEO) | Chief Executive Officer (CEO) | Proteome Systems (Group) | Australia |
Ellis, Geoff (Proteome Sciences 201605 Finance Director) | Chief Financial Officer (CFO) | Proteome Sciences (Group) | United Kingdom (GB) |
Haigh, Jeremy (Proteome Sciences 201606– CEO before Amgen European Chief Operating Officer + Merck) | Chief Executive Officer (CEO) | Proteome Sciences (Group) | United Kingdom (GB) |
Malthouse, James (Proteome Sciences 201006 Finance Director) | Chief Financial Officer (CFO) | Proteome Sciences (Group) | United Kingdom (GB) |
Pearce, Christopher (Proteome Sciences 201606– Non-executive Chairman before CEO) | Board member, non-executive | Proteome Sciences (Group) | United Kingdom (GB) |
Pike, Ian (Proteome Sciences 201009 COO) | Chief Operating Officer (COO) | Proteome Sciences (Group) | United Kingdom (GB) |
See, Chee Gee (Proteome Sciences 201310– Director Personalised Medicine with BusDev taks before Roche + GSK) | Business Development Manager / Strategy Manager | Proteome Sciences (Group) | United Kingdom (GB) |
Thompson, Andrew (Proteome Sciences 201409 Head of Chemical Proteomics) | Researcher (industry) | Proteome Sciences (Group) | United Kingdom (GB) |
Ward, Malcolm (Proteome Sciences 201009 CTO) | Chief Technology/Technical Officer (CTO) | Proteome Sciences (Group) | United Kingdom (GB) |
Groen, Arnoud (ProteiQ Biosciences GmbH 202010 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ProteiQ Biosciences GmbH | Germany |
Ausserer, Walter (Cell Biosciences 201004 VP Marketing) | Sales Manager / Marketing Manager | ProteinSimple (Group) | United States (USA) |
Harkness, Tim (Cell Biosciences 200909 CEO) | Chief Executive Officer (CEO) | ProteinSimple (Group) | United States (USA) |
Novi, Jason (ProteinSimple 201405 CFO) | Chief Financial Officer (CFO) | ProteinSimple (Group) | United States (USA) |
Ogino, Satoshi (ProteinSimple 201404– General Manager Japan Sales) | General Manager (management) | ProteinSimple (Group) | Japan |
Goddard, Paul (Protein Technologies 201201 CEO) | Chief Executive Officer (CEO) | Protein Technologies Ltd. (PTL) (GB) | United Kingdom (GB) |
Khan, Farid (Protein Technologies 201112 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Protein Technologies Ltd. (PTL) (GB) | United Kingdom (GB) |
Baldi, Alessandro (Protea Biosciences 201110– VP + General Manager before own consulting firm before PerkinElmer) | General Manager (management) | Protea Biosciences (Group) | United States (USA) |
Bolcato, Christopher A. (Chris) (Protea Biosciences 201009 Technical Services Manager) | Technical Manager | Protea Biosciences (Group) | United States (USA) |
Breaux, Jason (Protea Biosciences 201011 Director Bioanalytical Laboratory) | Laboratory Manager (industry) | Protea Biosciences (Group) | United States (USA) |
Goodman, Haddon (Protea Biosciences 201011 Product Marketing Manager) | Sales Manager / Marketing Manager | Protea Biosciences (Group) | United States (USA) |
Kilby, Greg (Protea 201404– Chief Bioanalytics Officer before Thermo Fisher + Agilent + Pfizer) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Protea Biosciences (Group) | United States (USA) |
Seeley, Erin (Protea 201404– Senior Lead Scientist MS Imaging before Vanderbuilt Univ) | Researcher (industry) | Protea Biosciences (Group) | United States (USA) |
Advertisement
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top